This is coming along nicely, will hold-off until the melanoma results come in. Spoiler alert there are a few surprises and some interesting observations.
1. The market opportunities are sizeable to say the least. Pharma may not pay for all indications until proven, so would lean towards larger milestone payments for each FTO indicator.
2. There are a stack of partnership opportunities albeit market is undervaluing all of them. The figures may or may not be a surprise to most!
Also, its early Q2 so happy if we get the Melanoma results on Monday : )
General Comments / Chat, page-5464
-
- There are more pages in this discussion • 5,765 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |